Ken Herrmann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ken Herrmann

Showing results (351-360 of 721) with videos related to

Pageof 73

Sort By:

Scientific Reports|September 2, 2021

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.

EJNMMI Physics|February 15, 2021

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.

Journal of Medical Imaging and Radiation Oncology|July 25, 2020

Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?Ole Martin, Nils-Martin Bruckmann, Julian Kirchner, et al.

Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 1, 2023

Quantification performance of silicon photomultiplier-based PET for small 18F-, 68Ga- and 124I-avid lesions in the context of radionuclide therapy planningDavid Kersting, Alexandros Moraitis, Miriam Sraieb, et al.

Lung Cancer (Amsterdam, Netherlands)|December 7, 2019

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2025

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPCTugce Telli, Leonor Lopes, Madeleine Karpinski, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023

Oncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CTTristan T Demmert, Kelsey L Pomykala, Helena Lanzafame, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019

PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential ExaminationsOle Martin, Benedikt M Schaarschmidt, Julian Kirchner, et al.

European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2015

iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?Christina Bluemel, Andreas Cramer, Christoph Grossmann, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008

Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy responseRupert Langer, Katja Ott, Katja Specht, et al.

Pageof 73

Search research articles

Showing results (351-360 of 721) with videos related to

Sort By:

Pageof 73

Scientific Reports|September 2, 2021

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.

EJNMMI Physics|February 15, 2021

Journal of Medical Imaging and Radiation Oncology|July 25, 2020

Lung Cancer (Amsterdam, Netherlands)|December 7, 2019

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2025

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPCTugce Telli, Leonor Lopes, Madeleine Karpinski, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019

PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential ExaminationsOle Martin, Benedikt M Schaarschmidt, Julian Kirchner, et al.

European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2015

iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?Christina Bluemel, Andreas Cramer, Christoph Grossmann, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008

Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy responseRupert Langer, Katja Ott, Katja Specht, et al.

Pageof 73